Does Dr. CHANDRAHAS AGARWAL have financial conflicts of interest?

Dr. CHANDRAHAS AGARWAL (M.D.) has received a total of $987 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $987 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CHANDRAHAS AGARWAL?

According to CMS Open Payments data, Dr. CHANDRAHAS AGARWAL received funding from ABIOMED ($148), BOEHRINGER INGELHEIM PHARMACEUTICALS ($132), and NOVARTIS PHARMACEUTICALS CORPORATION ($125).

Does Dr. CHANDRAHAS AGARWAL receive research grants or speaking fees?

Dr. CHANDRAHAS AGARWAL has received $987 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. CHANDRAHAS AGARWAL

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: RANCHO CUCAMONGA, CA 91730

NPI Number: 1528014172

LIFETIME INDUSTRY VALUE

$987

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AGARWAL is a verified Internal Medicine, Cardiovascular Disease practitioner based in RANCHO CUCAMONGA, CA.

Between 2021 and 2024, Dr. AGARWAL had an overall industry promotional and research financial footprint of $987 as recorded in the federal CMS Open Payments database.

$987 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGARWAL's primary funding source is ABIOMED, which accounts for $148 (representing 15% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABIOMED

Rank 1

$148

15%

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 2

$132

13.4%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$125

12.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.